Samuel F Huang

Melanoma of the penis, scrotum and male urethra: a 40-year single institution experience.

P. Tamboli, V. Prieto, C. Pettaway, 2005, The Journal of urology.

Inhibition of Growth and Metastasis of Orthotopic Human Prostate Cancer in Athymic Mice by Combination Therapy with Pegylated Interferon-- 2 b and Docetaxel

C. Bucana, C. Dinney, I. Fidler, 2002 .

Inhibition of growth and metastasis of orthotopic human prostate cancer in athymic mice by combination therapy with pegylated interferon-alpha-2b and docetaxel.

C. Bucana, C. Dinney, I. Fidler, 2002, Cancer research.

Total pelvic exenteration: effective palliation of perineal pain in patients with locally recurrent prostate cancer.

P. Pisters, A. Kamat, C. Pettaway, 2003, The Journal of urology.

The vascular-targeting fusion toxin VEGF121/rGel inhibits the growth of orthotopic human bladder carcinoma tumors.

C. Dinney, M. Rosenblum, P. Sweeney, 2005, Neoplasia.

Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production.

C. Dinney, D. Hicklin, B. Mian, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Anti-Vascular Endothelial Growth Factor Receptor 2 Antibody Reduces Tumorigenicity and Metastasis in Orthotopic Prostate Cancer Xenografts via Induction of Endothelial Cell Apoptosis and Reduction of Endothelial Cell Matrix Metalloproteinase Type 9 Production 1

C. Dinney, D. Hicklin, B. Mian, 2002 .